High-Dose-Rate Brachytherapy Schedules in Locally Advanced Cervical Cancer : A Systematic Review

Thiravud Khuhaprema, Pattarawin Attasara, Hutcha Sriplung, Suraporn Wiangnon, Yupa Sumitsawan, Suleeporn Sangrajrang, et al. Cancer in Thailand (204-2006). [Internet].2554. [cited 2016 Jun 14]. Available from: http://www. nci.go.th/en/File_download/ Nci%20Cancer%20 Registry/Cancer%20in%20thailand.pdf.

งานทะเบียนมะเร็ง โรงพยาบาลมะเร็งลำปาง. สถิติโรคมะเร็ง โรงพยาบาลมะเร็งลำปาง ปี พ.ศ. 2554. ลำปาง: ธนกิจการพิมพ์; 2554.

ปิยวัฒน์ เลาวหุตานนท์, อาคม ชัยวีระวัฒน์, เสาวคนธ์ ศุกรโยธิน, วีรวุฒิ อิ่มสาราญ, ธีรวุฒิ คูหะเปรมะ.แนวทางการตรวจคัดกรองวินิจฉัยและรักษาโรคมะเร็งปากมดลูก. กรงุเทพมหานคร: โฆสิตการพิมพ;์ 2556.

DeVita VT, Lawrence TS, Rosenberg SA. DeVita, Hellman, and Rosenberg’s Cancer: Principles & Practice of Oncology. Lippincott Williams & Wilkins; 2008. 17-48.

Treatment options for cervical cancer, by stage [Internet]. 2558. [cited 2016 Jun 14]. Available from: http://www.cancer.org/cancer/ cervicalcancer/detailedguide/cervical-cancertreating-by-stage

Perez CA, Breaux S, Bedwinek JM, Madoc-Jones H, Camel HM, Purdy JA, et al. Radiation therapy alone in the treatment of carcinoma of the uterine cervix. II. Analysis of complications. Cancer 1984; 54:235–46.

International Commission on Radiation Units & Measurements. Dose and Volume Specification for Reporting Intracavity Therapy in Gynecology [Internet]. 2016. [cited 2016 July 25]. Available from: https://www.scribd.com/doc/72099642/ icru-38.

Viani GA, Manta GB, Stefano EJ, de Fendi LI. Brachytherapy for cervix cancer: low-dose rate or high-dose rate brachytherapy – a meta-analysis of clinical trials. J Exp Clin Cancer Res 2009; 28:47.

Viswanathan AN, Beriwal S, De Los Santos JF, Demanes DJ, Gaffney D, Hansen J, et al. American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part II: high-dose-rate brachytherapy. Brachytherapy 2012; 11:47–52.

Tigeneh W, Kotzen J, Donde B. Prospective randomised study comparing three-fraction regimens of High Dose Rate Brachytherapy for cancer of the cervix stage IIB and IIIB. Afr J Haematol Oncol [Internet]. 2011 [cited 2016 Jul 4]. Available from: http://www.afjho.com/index. php/AJOHAO/article/view/27.

Forrest JL, Ackerman I, Barbera L, Barnes EA, Davidson M, Kiss A, et al. Patient outcome study of concurrent chemoradiation, external beam radiotherapy, and high-dose rate brachytherapy in locally advanced carcinoma of the cervix. Int J Gynecol Cancer 2010; 20:1074–8.

Tharavichitkul E, Klunkin P, Lorvidhaya V, Sukthomya V, Chakrabhandu S, Pukanhaphan N, et al. The effects of two HDR brachytherapy schedules in locally advanced cervical cancer treated with concurrent chemoradiation: a study from Chiang Mai, Thailand. J Radiat Res 2012; 53:281–7.

Julian PT, Douglas G, Jonathan AC, editors. 8 Assessing risk of bias in included studies [Internet]. 2011 [cited 2016 July 25]. Available from: http://handbook.cochrane.org/index. htm#chapter_8

Nam TK, Ahn SJ. A prospective randomized study on two dose fractionation regimens of high-dose-rate brachytherapy for carcinoma of the uterine cervix: comparison of efficacies and toxicities between two regimens. J Korean Med Sci 2004; 19:87–94.

Ferrigno R, dos Santos Novaes PE, Pellizzon AC, Maia MA, Fogarolli RC, Gentil AC, et al. Highdose-rate brachytherapy in the treatment of uterine cervix cancer. Analysis of dose effectiveness and late complications. Int J Radiat Oncol Biol Phys 2001; 50:1123–35.

Petereit DG, Pearcey R. Literature analysis of high dose rate brachytherapy fractionation schedules in the treatment of cervical cancer: is there an optimal fractionation schedule? Int J Radiat Oncol Biol Phys 1999; 43:359–66.

Orton CG. HDR: forget not “time” and “distance”. Int J Radiat Oncol Biol Phys 1991; 20:1131–2.

Toita T. Current status and perspectives of brachytherapy for cervical cancer. Int J Clin Oncol 2009; 14:25–30.

Hoeller U, Tribius S, Kuhlmey A, Grader K, Fehlauer F, Alberti W. Increasing the rate of late toxicity by changing the score? A comparison of RTOG/EORTC and LENT/SOMA scores. Int J Radiat Oncol Biol Phys 2003; 55:1013–8.